News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PhytoMedical Technologies, Inc. (PYTO.OB) Expands Anti-Cancer Research with Important Efficacy Tests



4/14/2008 9:39:33 AM

PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6), today announced that a series of positive outcomes from the Company’s ongoing development of its patented anti-cancer compounds have prompted researchers to now undertake their first-ever efficacy studies, an important advancement in the drug development process.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES